Author

Nina V. Kozlova

Beth Israel Deaconess Medical CenterORCID 0000-0002-4944-7917Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioinformatics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Assay:imaging· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Taru E. MuraneniD· 3 shared Antoine A. RuzetteiD· 2 shared John G. ClohessyiD· 2 shared Kayla A. CruziD· 2 shared Simon Flyvbjerg NørrelykkeiD· 2 shared Alex TokeriD· 1 shared Alica K. Beutel· 1 shared Alissandra L. HillisiD· 1 shared

Activity by Year

2024-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Taru E. MuranenORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioinformaticsbioRxivPreprintApr 28, 2025

An image analysis pipeline to quantify the spatial distribution of cell markers in stroma-rich tumors

Antoine A. Ruzette, Nina V. Kozlova, Kayla A. Cruz…·Simon Flyvbjerg Nørrelykke

The paper introduces an image analysis pipeline to quantify spatial biomarker distributions in stroma-rich tumors using open-source tools and custom scripts.

DOI 10.1101/2025.04.28.650414

mouseimaging

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 22, 2025

A novel DNA repair protein, N-Myc downstream regulated gene 1 (NDRG1), links stromal tumour microenvironment to chemoresistance

Nina V. Kozlova, Kayla A. Cruz, Hanna M. Doh…·Taru E. Muranen

This study identifies NDRG1 as a DNA repair protein that links pancreatic cancer stroma to chemoresistance by enhancing DNA damage repair through R-loop resolution.

4 citations

humanproteomics

𝕏 PostBluesky

Cancer BiologyCancer ResearchPeer-reviewedJul 18, 2024

Cholesterol biosynthesis inhibition synergizes with AKT inhibitors in triple-negative breast cancer

Alissandra L. Hillis, Timothy D. Martin, Haley E. Manchester…·Alex Toker

This study identifies a synergistic effect between AKT inhibitors and pitavastatin in killing triple-negative breast cancer cells by targeting cholesterol trafficking.

47 citationstop 2%

humangenetic perturbation / CRISPR

𝕏 PostBluesky